Yoshifumi Katakawa

Title: The Innovations of Yoshifumi Katakawa

Introduction

Yoshifumi Katakawa is a notable inventor based in Kusatsu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations of quinolone antibiotics. With a total of 3 patents to his name, his work has had a meaningful impact on medical treatments.

Latest Patents

Katakawa's latest patents focus on the formulation of orally administrable preparations that release quinolone antibiotics with a delay. The first patent, titled "Sustained-release preparations of quinolone antibiotics," describes a preparation that ensures the active compound is released over time. The second patent, "Method of preparing sustained-release preparations of quinolone antibiotics," outlines the process for creating these innovative formulations.

Career Highlights

Yoshifumi Katakawa is currently associated with Bayer Schering Pharma AG, a leading global pharmaceutical company. His work at Bayer has allowed him to explore and develop new pharmaceutical technologies that enhance the efficacy of antibiotic treatments.

Collaborations

Throughout his career, Katakawa has collaborated with esteemed colleagues, including Venkata-Rangarao Kanikanti and Roland Rupp. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshifumi Katakawa's contributions to the field of pharmaceuticals, particularly in the area of sustained-release antibiotic preparations, highlight his role as a significant inventor. His work continues to influence medical practices and improve patient outcomes.